石药集团明复乐药业（广州）有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
1
NMPA:1
Drug Approvals
Recombinant Human TNK Tissue-type Plasminogen Activator for Injection（rhTNK-tPA）
- Product Name
- 明复乐
- Approval Number
- 国药准字S20150001
- Approval Date
- Nov 13, 2019
NMPA
Clinical Trials
No trials found
News
No news found